XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2022     0        
Beginning balance at Dec. 31, 2022 $ 364,188   $ 0 $ 43 $ 611,739 $ (679) $ (246,915)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2022       42,832,231      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 7,363       7,363    
Stock option exercises (in shares)       80,938      
Stock option exercises 125       125    
Stock issued - on vested RSAs (in shares)       376,800      
Foreign currency translation 106         106  
Unrealized gain (loss) on available-for-sale securities 39         39  
Net loss (13,714)           (13,714)
Ending balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2023     0        
Ending balance at Mar. 31, 2023 358,107   $ 0 $ 43 619,227 (534) (260,629)
Ending balance, common stock, shares outstanding (in shares) at Mar. 31, 2023       43,289,969      
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2023   0 0        
Beginning balance at Dec. 31, 2023 $ 337,663   $ 0 $ 45 652,880 (345) (314,917)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2023 45,167,225     45,167,225      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 6,183       6,183    
Stock option exercises (in shares) 0            
Stock issued - on vested RSAs (in shares)       522,358      
Stock issued – on vested RSAs $ 1     $ 1      
Foreign currency translation (203)         (203)  
Unrealized gain (loss) on available-for-sale securities (18)         (18)  
Net loss (10,221)           (10,221)
Ending balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2024   0 0        
Ending balance at Mar. 31, 2024 $ 333,405   $ 0 $ 46 $ 659,063 $ (566) $ (325,138)
Ending balance, common stock, shares outstanding (in shares) at Mar. 31, 2024 45,689,583     45,689,583